“…Various solvents used in the crystallization process and different melting points reported earlier, for example, 244°C–246°C,5,6 246°C–248°C,4 and 258°C,7 may indicate the existence of several crystal polymorphic or solvatomorphic forms of BA. Solvatomorphism can be defined as the ability of the compound to form several crystal unit cells, which differ in their structure and elemental composition due to the inclusions of solvent molecules 9,10. It is well known that different polymorphs or solvatomorphs exhibit significantly different pharmaceutically relevant properties such as solubility, stability, density, or bioavailability, particularly when the drug substance is poorly soluble 9–11…”